Steve Gens on Muck Rack

Steve Gens

Yardley
As seen in: Medical Device and Diagnostic Industry (MDDI), Pharmaceutical Executive, Med Device Online, Clinical Leader, Life Science Leader, Bioprocess Online, Pharmaceutical Online, MedTech Intelligence, Outsourced Pharma, Cell & Gene and
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Steve

Contact Steve, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

06.11.26 -- Process Intensification: Your Guide To "Doing More With Less"

|
By Steve Gens, Ciera Clayton
| Biosimilar Development Verified
Process Intensification: Your Guide To "Doing More With Less" Explore innovative strategies in process intensification to boost mAb production and hear from industry experts as they share solutions for scaling efficiency and navigating regulatory challenges. Most organizations have modernized their global regulatory information management (RIM) systems and improved data quality. Yet modernization and readiness are not the same thing.
Open in Who Shared Issue with article?

06.04.26 -- Are Biotechs Wasting Time On The Wrong CDMO?

|
By Tamika Drummond, Steve Gens, Ciera Clayton
| Biosimilar Development Verified
Your Biosimilar, Your Journey With many blockbuster drug patents set to expire by 2030, the market is ripe for biosimilar developers to stake their claim. To succeed, they must be strategic and compliant. Biotechs often default to one of two flawed instincts: pursue the biggest name in the space or go with the lowest bidder. To avoid misalignment, look at these less visible factors.
Open in Who Shared Issue with article?

06.02.26 -- Why Are Life Science Companies So Poorly Prepared For RIM's Future?

|
By Steve Gens, Marty Reyes, Weiler Engineering
| Pharmaceutical Online Verified
Webinar: The Column and the Crystal: Purification Strategies for Small Molecule APIs Join this 2-part MilliporeSigma webinar series to discover how CDMOs overcome some of the toughest small molecule development challenges. Explore advanced crystallization strategies, digital chromatography tools, and innovative techniques like fraction mapping that improve purity, filtration, and scalability.
Open in Who Shared Issue with article?
See all 49 licensed articles (51 Total)
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified